Document is current
Any future updates will be listed below
-
Authors
Li, Hongmin
Ghorbani, Samira
Oladosu, Olayinka
Zhang, Ping
Visser, Frank
Dunn, Jeff
Zhang, Yunyan
Ling, Chang-Chun
Yong, V. Wee
Xue, Mengzhou
-
Funding
Funding for this research was provided by:
China Scholarship Council (202107040052)
Canadian Institutes of Health Research Grant (1049959)
National Natural Science Foundation of China (82071331)
National Key Research and Development Program of China (2018YFC1312200)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 30 December 2024
First Online: 4 January 2025
Declarations
:
: All animal experiments were performed with ethics approval (protocol number AC21-0073) from the Animal Care Committee at the University of Calgary under regulations of the Canadian Council of Animal Care.
: Not applicable.
: PZ, CCL and VWY are co-inventors in a US Provisional Patent application (US 63/720,938) titled: Fluorinated glucosamine analogs to reduce injury and promote recovery in neurological disorders.
